OMICENT Trademark

Trademark Overview


On Wednesday, September 12, 2012, a trademark application was filed for OMICENT with the United States Patent and Trademark Office. The USPTO has given the OMICENT trademark a serial number of 85726964. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 16, 2016. This trademark is owned by Eli Lilly and Company. The OMICENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants
omicent

General Information


Serial Number85726964
Word MarkOMICENT
Filing DateWednesday, September 12, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 16, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 18, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, May 16, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 16, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 21, 2015EXTENSION 5 GRANTED
Wednesday, September 16, 2015EXTENSION 5 FILED
Wednesday, September 16, 2015TEAS EXTENSION RECEIVED
Friday, February 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 26, 2015EXTENSION 4 GRANTED
Tuesday, February 17, 2015EXTENSION 4 FILED
Tuesday, February 17, 2015TEAS EXTENSION RECEIVED
Wednesday, October 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 30, 2014EXTENSION 3 GRANTED
Thursday, September 25, 2014EXTENSION 3 FILED
Thursday, September 25, 2014TEAS EXTENSION RECEIVED
Thursday, January 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 22, 2014EXTENSION 2 GRANTED
Thursday, January 2, 2014EXTENSION 2 FILED
Thursday, January 2, 2014TEAS EXTENSION RECEIVED
Tuesday, November 26, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2013EXTENSION 1 GRANTED
Monday, October 7, 2013EXTENSION 1 FILED
Tuesday, November 12, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 7, 2013TEAS EXTENSION RECEIVED
Tuesday, April 9, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 29, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 29, 2012ASSIGNED TO EXAMINER
Tuesday, September 18, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 15, 2012NEW APPLICATION ENTERED IN TRAM